Log In
BCIQ
Print this Print this
 

CJM112

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
Description mAb targeting interleukin-17 (IL-17)
Molecular Target Interleukin-17 (IL-17)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today